Filing Details

Accession Number:
0001127602-14-011384
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-12 19:20:54
Reporting Period:
2014-03-10
Filing Date:
2014-03-12
Accepted Time:
2014-03-12 19:20:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875045 Biogen Idec Inc. BIIB Biological Products, (No Disgnostic Substances) (2836) 330112644
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202102 A George Scangos Biogen Idec Inc.
225 Binney Street
Cambridge MA 02142
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-03-10 700 $327.76 53,689 No 4 S Direct
Common Stock Disposition 2014-03-10 1,200 $328.38 52,489 No 4 S Direct
Common Stock Disposition 2014-03-10 500 $329.06 51,989 No 4 S Direct
Common Stock Disposition 2014-03-10 900 $330.65 51,089 No 4 S Direct
Common Stock Disposition 2014-03-10 2,420 $331.55 48,669 No 4 S Direct
Common Stock Disposition 2014-03-10 3,280 $332.40 45,389 No 4 S Direct
Common Stock Disposition 2014-03-10 2,300 $333.61 43,089 No 4 S Direct
Common Stock Disposition 2014-03-10 5,673 $334.54 37,416 No 4 S Direct
Common Stock Disposition 2014-03-10 3,985 $335.25 33,431 No 4 S Direct
Common Stock Disposition 2014-03-10 3,001 $336.49 30,430 No 4 S Direct
Common Stock Disposition 2014-03-10 2,065 $337.25 28,365 No 4 S Direct
Common Stock Disposition 2014-03-10 100 $338.05 28,265 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,378 Indirect by Trust
Common Stock 5,378 Indirect by Trust
Footnotes
  1. Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
  3. This represents the weighted average price for shares sold at a range between $327.66 (low) and $327.92 (high).
  4. This represents the weighted average price for shares sold at a range between $328.01 (low) and $328.77 (high).
  5. This represents the weighted average price for shares sold at a range between $329.02 (low) and $329.09 (high).
  6. This represents the weighted average price for shares sold at a range between $330.33 (low) and $330.87 (high).
  7. This represents the weighted average price for shares sold at a range between $331.02 (low) and $331.99 (high).
  8. This represents the weighted average price for shares sold at a range between $332.00 (low) and $332.93 (high).
  9. This represents the weighted average price for shares sold at a range between $333.03 (low) and $333.98 (high).
  10. This represents the weighted average price for shares sold at a range between $334.06 (low) and $334.97 (high).
  11. This represents the weighted average price for shares sold at a range between $335.00 (low) and $335.99 (high).
  12. This represents the weighted average price for shares sold at a range between $336.04 (low) and $336.81 (high).
  13. This represents the weighted average price for shares sold at a range between $337.00 (low) and $337.81 (high).